scholarly article | Q13442814 |
P50 | author | Thomas J Hayman | Q83591176 |
Mokenge Malafa | Q89525393 | ||
Gregory M Springett | Q123509044 | ||
Sarah E Hoffe | Q123509045 | ||
Pamela Hodul | Q123509046 | ||
Ravi Shridhar | Q123509048 | ||
P2093 | author name string | Lodovico Balducci | |
Kenneth L Meredith | |||
Tobin Strom | |||
P2860 | cites work | Cancer statistics, 2014 | Q27861018 |
Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma | Q33733149 | ||
Age-specific cancer incidence rates increase through the oldest age groups | Q33994078 | ||
Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study | Q34334926 | ||
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer | Q34546440 | ||
Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection | Q34695255 | ||
Cancer in the elderly: pancreatic cancer | Q35992182 | ||
Never too old? Age should not be a barrier to enrollment in cancer clinical trials | Q36081341 | ||
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital | Q36572889 | ||
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). | Q37221905 | ||
Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older | Q37607501 | ||
Epidemiology of pancreatic cancer: an overview | Q37608905 | ||
Neoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation | Q38196485 | ||
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial | Q43804989 | ||
Pancreatic cancer survival in elderly patients treated with chemotherapy | Q45297574 | ||
Pancreatoduodenectomy with portal vein resection is feasible and potentially beneficial for elderly patients with pancreatic cancer | Q48080343 | ||
Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. | Q51732886 | ||
Pancreatic Cancer | Q54135367 | ||
Underrepresentation of patients 65 years of age or older in cancer-treatment trials | Q73311140 | ||
Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization | Q73735656 | ||
On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer | Q79955539 | ||
Pattern of lymph node metastasis spread in pancreatic cancer | Q83728951 | ||
P433 | issue | 5 | |
P921 | main subject | pancreatic cancer | Q212961 |
P304 | page(s) | 498-504 | |
P577 | publication date | 2015-10-01 | |
P1433 | published in | Journal of gastrointestinal oncology | Q26842467 |
P1476 | title | Outcomes of resected pancreatic cancer in patients age ≥70 | |
P478 | volume | 6 |
Q50024624 | Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis |
Q37412058 | Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First Approach. |
Q64094461 | Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies |
Q36095529 | Update on the Management of Pancreatic Cancer in Older Adults |
Search more.